COMMUNIQUÉS West-GlobeNewswire

Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
16/09/2025
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. ( “ Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc . (NASDAQ: TLRY and TSX: TLRY [...]
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
16/09/2025
In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given semaglutide alone [...]
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
16/09/2025
- Strategic expansion with trusted partner enhances customer reach HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider [...]
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance
16/09/2025
US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following Clearance Coronary Intravascular [...]
Immuneering Appoints Dr. Thomas Schall as Chairman of the Board
16/09/2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the appointment of Thomas J. Schall, Ph.D [...]
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
16/09/2025
Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks *1 ,2 Cagrilintide was well-tolerated, with the most [...]
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
16/09/2025
Posters support Ohtuvayre ® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq [...]
Strengthening Rabies Defence in Canada: CAHI Announces 2025 World Rabies Day Webinar
16/09/2025
OTTAWA, Ontario, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to continue its tradition of hosting a webinar in recognition of World Rabies Day. This year’s event, taking place [...]
Renforcer la lutte contre la rage au Canada : l’ICSA annonce son webinaire à l’occasion de la Journée mondiale contre la rage 2025
16/09/2025
OTTAWA, Ontario, 16 sept. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de santé animale (ICSA) est fier de poursuivre sa tradition en organisant un webinaire à l’occasion de la Journée mondiale contre la rage. L’ [...]
ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025
16/09/2025
Garching / Munich, Germany, September 16, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced that it will unveil dosimetry data from its recent Phase 3 [...]
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025
16/09/2025
Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview Updated safety and pharmacokinetic results of the Phase 1 trial [...]
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil
16/09/2025
Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne muscular dystrophy in Brazil. MILAN, Italy, September 16, 2025 – [...]
Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate, OVX836
16/09/2025
Phase 2b to assess efficacy, safety, and immunogenicity 2,850 participants to be enrolled across European countries Lyon, France and Liège, Belgium – September 16, 2025 – Osivax , a biopharmaceutical company developing [...]
Manchester charity recognises UK hero volunteers
16/09/2025
Human Appeal’s Purple Legacy Awards returned for the second year MANCHESTER, United Kingdom, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Manchester-based humanitarian charity, Human Appeal, announced its second awards ceremony, [...]
New Imprivata Report Finds that UK Hospitals Save More Than £522K Annually with Shared-Use Mobile Devices, but Gaps in Strategy Pose Risks
16/09/2025
The 2025 Imprivata State of Shared Mobile Devices in Healthcare Report reveals both opportunity and challenges for UK healthcare organisations to better leverage shared-use mobile devices in the delivery of patient care [...]
Cumulus Oncology Strengthens Board of Directors & Scientific Advisory Team
16/09/2025
Appoints Dr Manuel Aivado as Director and Dr Brian Jones as Scientific Advisor EDINBURGH, Scotland, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cumulus Oncology, an oncology and inflammation focused biotech , announces the [...]
Cantoni Therapeutics secures financing to advance novel non-incretin obesity drug into IND enabling phase
16/09/2025
Brabant Development Agency (BOM) and angel investor join lead investor Libertatis Ergo Holding (LEH) in providing funding, with additional financial support from Brabant Startup Fund (BSF) Cantoni awarded validatioNN [...]
Transforming Global Healthcare: Inteleos Debuts Sonography Certification at Eight New UAE Testing Centers
16/09/2025
New Locations Unlock Regional Access to Certification, Expand Opportunity for Professionals to Obtain ISO-Certified Credentials Healthcare credentialing leader advances equity and excellence in diagnostic ultrasound for [...]
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
16/09/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, September 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of [...]

Pages